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Downregulation of the miR-143/145 microRNA
(miRNA) cluster has been repeatedly reported in
colon cancer and other epithelial tumors. In addition,
overexpression of these miRNAs inhibits tumorigen-
esis, leading to broad consensus that they function
as cell-autonomous epithelial tumor suppressors.
We generated mice with deletion of miR-143/145 to
investigate the functions of these miRNAs in intesti-
nal physiology and disease in vivo. Although intesti-
nal development proceeded normally in the absence
of these miRNAs, epithelial regeneration after injury
was dramatically impaired. Surprisingly, we found
that miR-143/145 are expressed and function exclu-
sively within the mesenchymal compartment of
intestine. Defective epithelial regeneration in miR-
143/145-deficient mice resulted from the dysfunc-
tion of smooth muscle and myofibroblasts and was
associated with derepression of the miR-143 target
Igfbp5, which impaired IGF signaling after epithelial
injury. These results provide important insights into
the regulation of epithelial wound healing and argue
against a cell-autonomous tumor suppressor role
for miR-143/145 in colon cancer.INTRODUCTION
MicroRNAs (miRNAs) represent a broad class of 18–22 nucleo-
tide RNAs that negatively regulate the stability and translation
of target messenger RNAs. Although initially identified more
than 2 decades ago as developmental regulators in invertebrates
(Lee et al., 1993; Reinhart et al., 2000; Wightman et al., 1993),
subsequent evaluation of numerous miRNAs in worms, flies,
and mice has demonstrated that these transcripts rarely provide1104 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.essential functions during animal development (Miska et al.,
2007; van Rooij et al., 2007). Instead,miRNA deletion has repeat-
edly been associated with latent pathological defects exposed
only upon stressing or taxing an organ system (Leung and Sharp,
2010; Mendell and Olson, 2012). These experimental findings
have led to the suggestion that mammalian miRNAs commonly
function in vivo to buffer cells and tissues against stressors
and thereby maintain homeostasis.
In keeping with their roles in stress-activated pathways,
miRNAs have repeatedly emerged as important diagnostic
markers and therapeutic targets in human disease states. A
particularly important role for miRNAs in cancer pathogenesis
has been uncovered through the examination of human tumor
samples. Virtually all examined tumor types are characterized
by globally abnormal miRNA expression patterns and profiles
of miRNA expression are highly informative for tumor classifica-
tion, prognosis, and response to therapy (Kong et al., 2012; Lu
et al., 2005; Lujambio and Lowe, 2012). Moreover, numerous
reports have documented a functional contribution of specific
miRNAs to cellular transformation and tumorigenesis (He et al.,
2005; Medina et al., 2010). Among the first reported examples
of abnormal miRNA expression in human cancer was downre-
gulation of miR-143 and miR-145, two cotranscribed miRNAs,
in human colorectal adenocarcinoma (Michael et al., 2003).
This observation has been reproduced in numerous subsequent
studies (Bandre´s et al., 2006; Motoyama et al., 2009; Schepeler
et al., 2008; Slaby et al., 2007), and similar findings have been
reported in breast cancer, pancreatic cancer, and other solid
tumors of epithelial origin (Iorio et al., 2005; Papaconstantinou
et al., 2013; Takagi et al., 2009). In addition, functional studies
have demonstrated that ectopic expression of these miRNAs
inhibits proliferation, induces apoptosis, and/or suppresses
anchorage-independent growth and tumor-forming ability of
diverse cancer cell types in vitro and in vivo (Chen et al., 2009;
Clape´ et al., 2009; Kent et al., 2010; Sachdeva et al., 2009). These
effects are mediated, at least in part, by the direct repression of
oncogenes such as MYC and KRAS. Based on these data, it is
broadly accepted thatmiR-143/145 function as cell-autonomous
tumor suppressors in colon cancer and other epithelial tumor
types. Nevertheless, the natural functions of miR-143/145 in
the mammalian intestine and other epithelial tissues that un-
derlie their presumed tumor suppressor activity have not been
investigated.
The intestine is unique among mammalian tissues in the rate
and number of ongoing mitotic divisions it requires for homeo-
stasis. The rapid turnover of the intestinal epithelium depends
on the presence of renewing stem cells that can provide a contin-
uous supply of epithelial cells under basal conditions as well as
additional cells to re-establish the epithelial barrier after mucosal
injury (Barker et al., 2007; Sangiorgi andCapecchi, 2008; Takeda
et al., 2011; Tian et al., 2011; Yan et al., 2012). The delicate
balance between self-renewal and differentiation, as well as
robust responses to various insults, relies both on intrinsic
epithelial mechanisms and extrinsic signals from several sour-
ces, including local mesenchymal cells and immune cells.
Among the most important regulators of the intestinal epithelium
are pericryptal mesenchymal cells, sometimes referred to as
intestinal subepithelial myofibroblasts (ISEMFs), which occupy
a position just below the basement membrane of the epithelium.
ISEMFs provide important paracrine regulatory signals to intes-
tinal epithelial cells during normal physiologic turnover and in the
setting of wound repair (Madison et al., 2005; Otte et al., 2003;
Powell et al., 2011; Shao et al., 2006). The precise origin of
these cells is ill defined, but may include activation of resident
fibroblasts, dedifferentiation of local smooth muscle cells, or
even migration of bone marrow resident progenitors (Powell
et al., 2011). A comprehensive understanding of themechanisms
that regulate myofibroblast behavior after injury and the para-
crine factors that these and other stromal cells secrete to regu-
late epithelial proliferation and repair is of broad interest because
it may allow the co-option of these pathways for therapeutic
benefit.
To better understand the functions ofmiR-143/145 in intestinal
physiology and disease in vivo, we generated mice with consti-
tutional or tissue-restricted deletion of these miRNAs. While
miR-143/145 loss-of-function had no overt effect on intestinal
development, we uncovered an essential role for these miRNAs
in the epithelial regenerative response induced by intestinal
injury. Surprisingly, this phenotype was entirely attributable
to a mesenchymal function, as demonstrated by a complete
absence of miR-143/145 expression in the intestinal epithelium
and lineage-specific deletion studies. Furthermore, we provide
evidence that the observed defect in epithelial regeneration is
mediated by aberrant paracrine signaling by smooth muscle
and myofibroblasts. These findings provide important insight
into the functions of miR-143/145 in intestinal physiology and
tumorigenesis and contribute to our understanding of the mech-
anisms that govern epithelial repair in this tissue.
RESULTS
Normal Baseline Intestinal Architecture and Turnover in
miR-143/145/ Mice
To study the physiologic functions of miR-143/145 in the intesti-
nal epithelium in vivo, we generated mice harboring miR-143/
145flox (miRflox) andmiR-143/145null (miR–) alleles using standardhomologous recombination techniques (Figure S1A available
online). As expected, miR-143/145 were undetectable in miR–/–
animals whereas miRflox/flox animals exhibited normal levels of
the miRNAs in the absence of Cre (Figures 1A and S1B). As
reported elsewhere, germline deletion of these miRNAs resulted
in no overt developmental defects and the targeted alleles were
transmitted at the expected Mendelian ratios (data not shown)
(Boettger et al., 2009; Xin et al., 2009).
Detailed histologic examination of adult (8–10 weeks of age)
wild-type (miR+/+) and miR–/– mice did not reveal any overt ab-
normalities in the architecture of the intestinal crypt or villus com-
partments in small and large intestines (Figure 1B and data not
shown). Bromodeoxyuridine (BrdU) pulse-chase experiments
demonstrated equivalent BrdU uptake and epithelial turnover
rates in miR+/+ and miR–/– intestines (Figure S2). Thus, miR-
143/145 are dispensable for normal small and large intestinal
development in the mouse and do not appreciably regulate the
baseline rate of epithelial turnover in this tissue.
Lethal Failure of Intestinal Regeneration in
miR-143/145–/– Mice
To assess whether a latent stress-induced defect exists in the in-
testines ofmiR–/– mice, we administered dextran sulfate sodium
(DSS), which induces a well-tolerated epithelial injury-regen-
eration sequence in wild-type animals (Clapper et al., 2007).
Following 5 days of DSS administration via drinking water, con-
trol mice exhibited transient weight loss and severe acute colitis,
leaving patches of completely de-epithelialized mucosa (Figures
S3A and S3B). This was followed by a robust regenerative
response, evident by 2 days after removal of DSS (experimental
day 5+2, hereafter referred to as D5+2), characterized by the
presence of elongated, hyperproliferative crypts in ulcer-adja-
cent areas that stained positively for Ki67 and phosphorylated
histone H3 (pH3, a mitotic marker) throughout their lengths,
but lacked differentiated goblet cells (Figure 1C). Near complete
restoration of the intestinal mucosal architecture was achieved
by 9 days after DSS injury (data not shown). Surprisingly, when
miR–/– animals were subjected to the identical DSS treatment,
a majority succumbed to fulminant disease by D5+2 (Figure 1D).
Grossly, the colons of these animals uniformly appeared dis-
tended, hemorrhagic, and necrotic (Figure 1E).
The mortality of miR–/– mice following exposure to DSS could
result from more extensive epithelial injury or a failure to regen-
erate the damaged epithelium. Weight loss of wild-type and
knockout mice after DSS treatment was indistinguishable,
suggesting equivalent injury (Figure S3A). Similarly, histologic
evidence of tissue injury and apoptosis on experimental day 5
were comparable between miR+/+ and miR–/– animals (Fig-
ure S3B). However, despite the similar appearance of wild-
type and knockout colons immediately after exposure to DSS,
miR–/–mice exhibited a striking deficiency of regenerating crypts
after injury (D5+2) (Figure 1C). In miR–/– mice, ulcer-adjacent
crypts remained exclusively in the nonregenerative state with
numerous goblet cells and proliferation limited to the base.
Together, these data indicate that mortality following DSS treat-
ment in miR–/– mice is specifically attributable to a failure of the
intestinal epithelium to mount a regenerative response following
injury.Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc. 1105
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Figure 1. Lethal Failure of Intestinal Regeneration in miR-143/145–/– Mice
(A) Northern blot analysis of bladder miRNA expression in mice of indicated genotypes.
(B) H&E-stained colon sections of adult miR+/+ and miR–/– mice. Representative images from at least five mice of each genotype are depicted. These and all
subsequent microscopy images were acquired using the MosaiX/Stitching function of AxioVision, which produces a composite image of multiple adjacent fields.
(C) Proliferation of ulcer-adjacent crypts assessed by H&E (upper panels), Ki67, and pH3 staining. Histology (H&E) was examined in over 20 mice of each
genotype while a subset of sections (nR 3) were further stained for Ki67 and pH3.
(D) Kaplan-Meier survival curves of miR+/+, miR+/–, and miR–/– mice, administered 3.5% DSS in drinking water for 5 days. *p < 0.0001, log rank test.
(E) miR+/+ and miR–/– animals necropsied 2 days after completion of DSS treatment. Images are representative of over 20 mice examined per genotype.
See also Figures S1, S2, and S3.miR-143/145 Are Exclusively Expressed in the Intestinal
Mesenchyme
The regenerative failure inmiR–/–mice could result either from an
intrinsic epithelial proliferative defect or from a non-cell-autono-
mous abnormality in a supporting cell population that produces
one or more critical paracrine factors. In order to distinguish be-
tween these possibilities, we first examined the miR-143/145
expression domain in mouse colon using in situ hybridization
(ISH) (Figures 2A and 2B). Robust miR-143/145 expression
was detected in the mesenchymal cells of the intestine, espe-
cially in smooth muscle cells as reported elsewhere (Boettger
et al., 2009; Xin et al., 2009) and in pericryptal cells located
in a position consistent with lamina propria myofibroblasts. In
contrast, expression of these miRNAs was not detectable within1106 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.intestinal epithelial cells, contrary to some previously reported
ISH studies (Zhu et al., 2011).
Because these data were at odds with a large body of pub-
lished literature that implicatesmiR-143/145 as cell-autonomous
tumor suppressors in the intestine, wemeasuredmiRNA expres-
sion in purified epithelial cells using a more sensitive quantitative
reverse transcription PCR (qRT-PCR) assay. Consistent with
our ISH findings, miR-143 and miR-145 were easily detectable
in whole colon but nearly undetectable by PCR in mouse (Fig-
ure 2C) and human (Figure 2D) epithelial preparations. We also
considered the possibility that miR-143/145 might be selectively
induced in epithelial cells following injury, but crypt isolation dur-
ing and after DSS treatment revealed an identical nonepithelial
expression pattern at all time points (Figure S4A).
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Figure 2. miR-143/145 Are Exclusively Expressed in the Intestinal Mesenchyme
(A) In situ hybridization analysis of miR-143 and miR-145 expression in mouse colon. Representative images from three animals per genotype are shown. Blue,
miRNA; red, nuclear fast red counterstain.
(B) In situ hybridization (left) showing miR-143/145-expressing pericryptal cells located in a position consistent with SMA+ lamina propria myofibroblasts (right).
(C) Quantitative RT-PCR analysis of mRNA and miRNA expression in full-thickness mouse colon specimens and purified epithelium. The purity of epithelial
preparations was demonstrated by enrichment of the epithelial markers Villin (Vil) and E-cadherin (Cdh1) and near-complete depletion of the mesenchymal
transcripts smooth muscle actin (Sma) and vimentin (Vim). nR 3 samples per condition. For this and all subsequent figures, error bars represent SDs.
(D) mRNA and miRNA expression in human colorectal tumor and paired normal colon specimens and in corresponding purified epithelium. n = 10 samples per
condition. *p < 0.05 (Student’s t test).
(E) Quantitative RT-PCR analysis of miR-143/145 expression in purified intestinal epithelial cells (IEC), isolated epithelial stem cells (Lgr5+), and ISEMFs,
compared to full-thickness colon specimens.
See also Figure S4.A low level of amplification of miR-143/145 in purified epithe-
liumwasmost likely due to residual contaminatingmesenchymal
cells in these preparations. To address this possibility directly,
we took advantage of our conditional miRflox allele, which can
be deleted in specific lineages using appropriate Cre driver lines.
Previously characterized Villin-Cre (Madison et al., 2002) and
Twist2+/Cre (Geske et al., 2008; Sosic et al., 2003) mice were ob-
tained and crossed to miRflox animals. The Villin-Cre transgene
directs recombination in all cells of the GI tract epithelium,
whereas the Twist2Cre allele drives Cre expression in early
mesenchymal cells but, importantly, spares bone marrow cells
(Yu et al., 2003). We confirmed the specificity of both Cre linesby crossing to ROSA26LSL-LacZ reporter mice (Figure 3A) and
directly examining recombination of the miR-143/145 locus in
small and large intestine (Figure S5A). Additionally, a low level
of recombination in total bone marrow cells, hematopoietic
stem cells, and major hematopoietic lineages was confirmed
in Twist2Cre/+; miRflox/flox animals (Figure S5B). miR-143 and
miR-145 levels in whole colonwere unchanged inVillin-Cre; miR-
flox/flox animals compared to control littermates, indicating that
the detectable miR-143/145 expression in this tissue does not
derive from the epithelial compartment (Figure S5C). In contrast,
Twist2Cre; miRflox/flox animals displayed greatly reduced miR-
143/145 expression in whole colon and undetectable expressionCell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc. 1107
A D
E
B
C
Figure 3. Mesenchymal, but Not Epithelial, miR-143/145 Deletion Phenocopies Germline Deletion
(A) X-gal-stained colon sections demonstrating domains of Cre-mediated recombination in mice of the indicated genotypes. Blue, LacZ expression; red, nuclear
fast red counterstain.
(B) Colons frommice of the indicated genotypes, dissected 2 days after completion of DSS treatment. Representative images are from five to ten examined mice
per genotype.
(C) Kaplan-Meier survival curves of mice of indicated genotypes, administered 3.5% DSS in drinking water for 5 days. *p = 0.001, log rank test.
(D) Proliferation of ulcer-adjacent crypts assessed by H&E (top), Ki67, and pH3 staining. Histology (H&E) was examined in five to tenmice of each genotype, while
a subset of sections (nR 3) were further stained for Ki67 and pH3.
(E) Quantification of the average number of pH3+ cells within 500 mm of de-epthelialized zones. Multiple ulcer-adjacent areas in at least three mice per genotype
were quantified. **p < 0.01 (Student’s t test).
See also Figure S5.in purified epithelium, supporting a mesenchymal-restricted
expression domain.
We further considered the possibility that miR-143/145 might
be expressed exclusively in rare intestinal stem cells (ISCs) and
that analysis of bulk epithelial preparations might therefore be
insufficiently sensitive to detect them. Fluorescence-activated
cell sorting (FACS) was used to purify ISCs from Lgr5+/eGFP
mice (Barker et al., 2007), revealing undetectable levels of
miR-143/145 in this epithelial-derived population (Figure 2E).
On the contrary, miR-143/145 were readily expressed in primary
intestinal subepithelial myofibroblasts (ISEMFs) isolated from1108 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.newborn mouse colon (Shaker et al., 2010). Collectively, the
data from ISH, purified epithelial preparations, sorted ISCs,
and cultured ISEMFs conclusively demonstrate that miR-143/
145 expression is restricted to the intestinal mesenchyme
in human and mouse.
miR-143/145 Are Not Expressed in Colorectal Tumor
Epithelium
These data suggest that the apparent downregulation of
miR-143/145 that has been repeatedly observed in colorectal
cancer is the result of a sampling artifact due to depletion of
mesenchymal cells in tumors relative to normal mucosal bi-
opsies typically used as a basis of comparison. To examine
this possibility, we obtained biopsies of human colorectal can-
cers and paired normal colon and measured miR-143/145 levels
in the unfractionated tissue as well as in purified epithelium.
As reported, miR-143/145 levels were significantly lower in
whole tumors compared to whole colon samples (Figure 2D).
miR-143/145 in purified epithelial cells from the same biopsies,
however, were detectable only at background levels. Thus,
the reduced levels of these miRNAs that is observed when
comparing tumors to normal tissue is not due to their downregu-
lation in tumor epithelial cells.
Lastly, we addressed the possibility that miR-143/145 are
induced in intestinal epithelium as a protective mechanism
against transformation following an initial oncogenic hit and
then later silenced as tumorigenesis progresses. Among the
earliest and most common oncogenic lesions in colorectal can-
cer is loss of the APC tumor suppressor gene and consequent
constitutive activation of the Wnt/b-catenin pathway. Apcmin/+
mice harbor a heterozygous truncating mutation in Apc and, as
a result, develop numerous intestinal adenomas due to biallelic
Apc loss-of-function (Haigis et al., 2002; Lamlum et al., 2000).
As observed in human tumors, whole Apcmin adenomas exhibit
lower levels of miR-143/145 compared to wild-type intestine
(Figure S4B). Importantly, levels of miR-143/145 remain at back-
ground levels in purified epithelial cells from these adenomas.
Thus, although it remains formally possible that other oncogenic
pathways activate expression of thesemiRNAs in epithelial cells,
this is not a feature of the Wnt/b-catenin pathway that is hyper-
active in the majority of human colorectal cancers.
Mesenchymal, but Not Epithelial, miR-143/145 Deletion
Phenocopies Germline Deletion
Despite the extensive evidence that miR-143/145 expression
is absent in the intestinal epithelial compartment, it remained
formally possible that levels of these miRNAs below the limit of
detection were sufficient to support a function within epithelial
cells. To address this possibility, Villin-Cre and Twist2+/Cre ani-
mals were used to induce miR-143/145 loss-of-function specif-
ically within epithelial or mesenchymal lineages, respectively.
FollowingDSS injury, colons of Villin-Cre; miRflox/floxmice grossly
resembled wild-type and Villin-Cre; miR+/+ colons (Figure 3B)
and histologic evidence of robust epithelial regeneration
was present including numerous elongated, hyperproliferative
crypts flanking ulcerated areas (Figure 3D). Quantification of
pH3+ cells in ulcer-adjacent zones demonstrated equivalent
numbers in miR+/+, Villin-Cre; miR+/+, and Villin-Cre; miRflox/flox
mice (Figure 3E). Thus, epithelial deletion of miR-143/145 is fully
compatible with normal regeneration. Conversely, Twist2+/Cre;
miRflox/flox, but not Twist2+/Cre;miR+/+, animals displayed hemor-
rhagic and necrotic colons upon gross inspection and exhibited
elevated mortality after DSS treatment with kinetics similar to
miR–/– mice (Figures 3B and 3C). Hyperproliferative crypts
were absent in Twist2+/Cre; miRflox/flox animals and pH3+ cells
were restricted to the crypt base and reduced in number (Figures
3D and 3E). We conclude from these results that the functions
of these miRNAs are exclusively performed within the mesen-
chymal compartment of the intestine.Evidence for Smooth Muscle and Myofibroblast
Dysfunction in miR-143/145–/– Mice
A role for smooth muscle in the regulation of intestinal epithelial
regeneration has not previously been documented. Yet given
the prominent smooth muscle expression of miR-143/145 as
reported elsewhere (Boettger et al., 2009; Xin et al., 2009) and
confirmed by our ISH studies (Figure 2A), we sought to
determine whether dysfunction of this cell type underlies the
regenerative failure in miR–/– mice. To this end, miRflox mice
were crossed to transgenic Myh11-Cre/eGFP mice (Xin et al.,
2002), which direct Cre and eGFP expression under the control
of the murine smooth muscle myosin heavy chain (smMHC) pro-
moter. In colon tissues from these mice, transgene expression
was restricted to the muscularis propria, muscularis mucosae,
and rare lamina propria cells (see Figure 5D).
Colons of compound Myh11-Cre/eGFP; miR–/flox mice were
grossly abnormal after DSS treatment (Figure S6A), although
the hemorrhage and necrosis did not reach the full extent
characteristic of miR–/– and Twist2+/Cre; miRflox/flox colons after
injury. Histological analysis of Myh11-Cre/eGFP; miR–/flox intes-
tines confirmed significantly impaired epithelial regeneration
compared to Myh11-Cre/eGFP; miR+/+ and miR/flox mice, as
measured by hematoxylin and eosin (H&E) staining, Ki67 expres-
sion, and enumeration of pH3+ cells in ulcer-adjacent zones (Fig-
ures 4A and 4B). These results demonstrate that dysfunction of
intestinal smooth muscle measurably contributes to the defec-
tive regenerative response of miR–/– mice, while the reduced
severity of disease in Myh11-Cre/eGFP; miR–/flox compared to
miR–/– and Twist2+/Cre; miRflox/flox animals suggests a possible
contribution of additional nonsmooth muscle lineages in the
mesenchyme.
In addition to smoothmuscle, ISH documented strong expres-
sion of miR-143/145 in pericryptal cells of the lamina propria,
located in a position consistent with intestinal subepithelial
myofibroblasts (ISEMFs) (Figure 2B). Accordingly, we observed
robust miR-143/145 expression in cultured primary ISEMFs
(Figure 2E). Given that myofibroblasts are known to act as major
regulators of epithelial cell proliferation in normal physiology and
during wound repair (Powell et al., 2011), we hypothesized that
dysfunction of this cell type contributed to regenerative failure
inmiR–/–mice. The morphology of lamina propria myofibroblasts
was identical inmiR+/+ andmiR–/– colons prior to DSS treatment,
as documented by smooth muscle actin (SMA) staining (Fig-
ure 5A). After injury, myofibroblasts in wild-type colons up-
regulated SMA and underwent a dramatic reorganization within
ulcerated zones, adopting an elongated configuration with highly
parallel basal-luminal orientation (Figure 5B). Strikingly, myofi-
broblasts within ulcers of miR–/– mice were disorganized and
failed to elongate along the basal-luminal axis. Identical morpho-
logic abnormalities were present in Twist2+/Cre; miRflox/flox
colons, while myofibroblasts in Villin-Cre; miRflox/floxmice resem-
bled those in wild-type (Figure 5C). To our surprise, we also
observed morphologically abnormal myofibroblasts in the ulcer-
ated regions of Myh11-Cre/eGFP; miR–/flox colons, despite re-
striction of Cre expression to smooth muscle. Importantly, the
presence of the Villin-Cre, Twist2Cre, andMyh11-Cre/GFP alleles
alone did not result in myofibroblast disorganization after injury
(Figure S6B). Thus, in every assayed genotype, regenerativeCell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc. 1109
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Figure 4. Defective Epithelial Regeneration of Myh11-Cre/eGFP; miR–/flox Mice
(A) Proliferation of ulcer-adjacent crypts in mice of the indicated genotypes assessed by H&E (top), Ki67, and pH3 staining. Histology (H&E) was examined in 8–24
mice of each genotype, while a subset of sections (nR 3) were further stained for Ki67 and pH3.
(B) Quantification of the average number of pH3+ cells within 500 mm of de-epthelialized zones. Multiple ulcer-adjacent areas in at least three mice per genotype
were quantified. **p < 0.01 (Student’s t test).
See also Figure S6.failure was associatedwith abnormalmyofibroblast morphology,
suggesting a role for this cell type in the miR–/– DSS phenotype.
Smooth Muscle Gives Rise to a Population of Lamina
Propria Myofibroblasts following Colonic Epithelial
Injury
The precise origin of the organized myofibroblasts in ulcers
of wild-type mice after DSS injury is unclear, as they have
not been reported previously. In other settings, myofibroblasts
have been reported to arise from pre-existing myofibroblasts,
activated fibroblasts, smooth muscle cells, and even bone
marrow-derived cells (Powell et al., 2011). Given the surprising
finding that smooth muscle ablation of miR-143/145 led to
abnormal myofibroblasts in the lamina propria, we tested
whether myofibroblasts in DSS ulcers are derived from smooth
muscle. Myh11-Cre/eGFP; Rosa26mTmG/+ mice (Muzumdar
et al., 2007) were generated in order to label smoothmuscle cells1110 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.and their descendants with permanent GFP expression, even af-
ter inactivation of the Myh11 promoter. Indeed, we found a sig-
nificant number of smooth muscle-derived lamina propria cells
present within DSS-induced ulcers (Figure 5D). All theGFP+ cells
coexpressed SMA (Figure S6C), consistent with a myofibroblast
identity. Interestingly, a subset of myofibroblasts did not express
GFP, suggesting that these cells arise frompreexistingmyofibro-
blasts or other nonsmooth muscle lineages. Taken together,
these results support amodel whereby smoothmuscle and other
mesenchymal lineages contribute to the myofibroblast pool,
which in turn regulates epithelial regeneration following injury.
Derepression of Igfbp5 in miR-143/145–/–
Myofibroblasts Correlates with Intestinal Regenerative
Failure
The abnormal morphology of lamina propria myofibroblasts after
deletion of miR-143/145 suggests that dysfunction of this cell
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Figure 5. Disorganized Myofibroblasts Are Associated with Defective Epithelial Regeneration
(A) SMA immunofluorescence showing muscularis mucosa and pericryptal myofibroblasts in uninjured miR+/+ and miR–/– colons. Images representative of
greater than or equal to ten animals of each genotype.
(B and C) SMA immunofluorescence showing muscularis mucosa and pericryptal myofibroblasts in ulcerated regions of colon from mice of the indicated
genotypes 2 days after completion of DSS treatment. Images representative of greater than or equal to tenmiR+/+ andmiR–/– animals and greater than or equal to
three animals of the other genotypes.
(D) GFP fluorescence showing labeled smooth muscle cells and their progeny inMyh11-Cre/eGFP; mTmGmice (right) before and after DSS injury, compared to
Myh11-Cre/eGFP alone (left). White arrowheads show representative smooth muscle-derived cells that have migrated into the lamina propria. Images are
representative of three animals per genotype.
See also Figure S6.type contributes to the observed regenerative failure. We hy-
pothesized that dysregulation of one or more critical paracrine
signaling molecules produced by these cells contributes to the
DSS phenotype. To identify such factors, we performed global
mRNA expression profiling ofmiR+/+ andmiR–/– primary ISEMFs
under standard culture conditions and, to model inflammatory
stress, after exposure to bacterial lipopolysaccharide (LPS).
Among transcripts upregulated by 2-fold or more in miR–/– cells
in at least one of the assayed conditions was Insulin-like growth
factor binding protein 5 (Igfbp5) (Table S1), which is predicted to
be a target of miR-143 by the Targetscan algorithm (Friedman
et al., 2009). IGFBP5 is a secreted negative regulator of IGF
signaling that binds and sequesters IGF ligands (Pollak, 2008).
IGF signaling, in turn, is known to stimulate intestinal epithelial
proliferation and promotes recovery after DSS treatment
(Howarth et al., 1998). qRT-PCR validated the upregulation of
Igfbp5 in miR–/– ISEMFs and, notably, in whole colons exclu-
sively after DSS injury (Figure 6A). Although no other predicted
miR-143/145 targets were upregulated >2-fold inmiR–/– ISEMFs,
microarray analysis did reveal upregulation of Bone morpho-
genic protein 4 (Bmp4), a known inhibitor of intestinal epithelialproliferation (He et al., 2004), and Insulin-like growth factor bind-
ing protein 4 (Igfbp4), a negative regulator of both the IGF and
Wnt pathways (Zhu et al., 2008) (Table S1). While qRT-PCR
validated the upregulation of these transcripts in ISEMFs (Fig-
ure S7A), they were not differentially expressed in healthy or
DSS-injuredmiR+/+ andmiR–/– colons (Figure S7B) and therefore
were not studied further.
To further investigate the role of Igfbp5 in the regenerative
failure characteristic ofmiR–/– mice, we next validated the direct
regulation of this transcript by miR-143. Reporter assays, in
which the highly conserved predicted miR-143 binding sites
from the human and mouse 30 UTRs of Igfbp5 (Figure 6B) were
cloned downstream of luciferase, demonstrated that these se-
quences are sufficient to confer direct repression by this miRNA
(Figure 6C). Colonic Igfbp5 expression was then directly as-
sessed by ISH before and after DSS injury. Irrespective of geno-
type, Igfbp5 was minimally expressed under basal conditions
and in histologically uninjured regions of colon after DSS treat-
ment (Figure 6D, upper panels). In injured wild-type colons,
ISH revealed detectable but modest induction of Igfbp5 in the
lamina propria, muscularis mucosae and muscularis propriaCell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc. 1111
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Figure 6. Derepression of Igfbp5 in miR-143/145–/– Myofibroblasts In Vitro and In Vivo
(A) Quantitative RT-PCR analysis of Igfbp5 expression in cultured ISEMFs with or without LPS treatment and in whole mouse colons with or without DSS
administration. n = 3 independently-derived WT or KO ISEMF cell lines or animals per condition. *p < 0.05 (Student’s t test).
(B) Sequence and evolutionary conservation of the miR-143 binding site in the 30 UTR of Igfbp5. Mutations introduced into luciferase reporters (C) are indicated
in red.
(C) Relative firefly luciferase activity of reporter constructs containing themiR-143 binding site or its mutated version following transfection into 293T cells alone or
with control or miR-143 or miR-145 synthetic miRNA mimics. n = 3 replicates per condition. *p < 0.05; **p < 0.01 (Student’s t test).
(D) In situ hybridization analysis of Igfbp5 expression in DSS-treated miR+/+ and miR–/– colon sections. Top, uninjured regions; bottom, ulcerated regions with
residual crypts on the left. n = 7–8 mice per genotype examined. Blue, Igfbp5; red, nuclear fast red counterstain.
(E) Phospho-IGF1R (pIGF1R) immunofluorescence of ulcer-adjacent crypts in DSS-treatedmiR+/+ andmiR–/– colons. Quantification of membrane fluorescence
from n = 4mice of each genotype is shown in graph on right. Arrowheads, baso-lateral membranes of ulcer-adjacent crypts with (solid) or without (open) activated
IGF1R. **p < 0.01 (Student’s t test).
See also Figure S7.specifically in ulcerated regions of the colon. In miR–/– animals,
however, Igfbp5 was dramatically upregulated within these
domains, consistent with the quantitative RT-PCR (qRT-PCR)
data and confirming robust derepression of this target in the
absence of miR-143/145 in vivo. The high concentration of
IGFBP5 in ulcerated regions ofmiR–/– colons would be predicted
to compete strongly for soluble IGF ligand. Indeed, we observed
dramatically reduced IGF1 receptor (IGF1R) activation on the ba-
solateral membranes of ulcer-adjacent crypts in miR–/– mice, as
revealed by staining for the phosphorylated receptor (Figure 6E).
miR-143/145 deletion therefore directly derepressed Igfbp51112 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.expression in vitro and in vivo, resulting in impaired IGF signaling
which likely contributed to regenerative failure after DSS-medi-
ated injury.
DISCUSSION
Our in vivo analyses of miR-143/145 functions in intestinal
biology have yielded several surprising findings. First, loss
of miR-143/145 causes a profound defect in intestinal epithelial
regeneration. Second, lineage-specific deletion establishes that
this phenotype is entirely attributable to mesenchymal, rather
than epithelial, loss of function. Third, miR-143/145 are ex-
pressed solely in the mesenchymal cells of the intestine and,
therefore, are unlikely to execute cell-autonomous epithelial
functions as previously proposed. Last, we present evidence
that the observed phenotype is associated with myofibro-
blast-dependent paracrine inhibition of the IGF signaling
pathway. Together, these data establish a role for miR-143/
145 in intestinal homeostasis and implicate smooth muscle-
derived cells as critical regulators of intestinal regeneration in
the mouse.
These results have clear implications for the functions of miR-
143/145 in intestinal physiology and disease. These miRNAs,
owing to their mesenchymal-restricted expression domain,
clearly do not function as cell-autonomous regulators of epithe-
lial proliferation, nor are they likely to function as cell-autono-
mous tumor suppressors in intestinal cancers. Importantly,
despite recent reports from the study of other tissues (Hergen-
reider et al., 2012), we find no evidence of transfer of mature
miR-143 or miR-145 from mesenchymal cells to epithelial cells,
as this scenario would result in detectable levels of the mature
miRNAs in recipient cells. Moreover, although downregulation
of miR-143/145 in colorectal tumors was one of the earliest,
and since most reproduced, observations of abnormal miRNA
expression in cancer, our data argue that these findings were
confounded by sampling bias during tissue isolation. Because
tumor samples are depleted in smooth muscle and mesen-
chyme compared to mucosal biopsies, tumor specimens could
artifactually appear to have downregulated miR-143/145 levels
when compared to normal tissue. Indeed, by purifying epithelial
cells from a set of tumors that appeared to exhibit miR-143/145
downregulation, we showed that the miRNAs are not expressed
in the normal or tumor epithelial compartment and thus are not
downregulated in the cancer cells themselves. We further
demonstrated that an early, common oncogenic lesion in colo-
rectal cancer, loss of the Apc gene, does not result in an induc-
tion of miR-143/145 in epithelial cells. Although it remains
formally possible that other oncogenic pathways result in de
novo activation of miR-143/145 expression in tumor cells, this
scenario is not supported by existing data. Of note, our data
do not contradict the potent antitumor activities that these
miRNAs have been shown to exhibit upon enforced ectopic
expression in epithelial cancer cells. Indeed, the expression of
developmental lineage ‘‘inappropriate’’ miRNAs might repre-
sent a therapeutic avenue deserving of further study.
In addition to their potential role as tumor suppressors,
miR-143/145 have been extensively studied in the context of
vascular smooth muscle biology. A large number of reports
have documented abundant expression of miR-143/145 in
vascular smooth muscle cells (VSMCs) and have demonstrated
a functional role for these miRNAs in the phenotypic responses
of VSMCs to blood vessel injury (Boettger et al., 2009; Cheng
et al., 2009; Cordes et al., 2009; Xin et al., 2009). In the setting
of vascular injury, smooth muscle cells undergo phenotypic
switching from a contractile to a migratory and secretory state,
after which they contribute to neointima formation. Our analyses
of myofibroblast origin and function after intestinal injury have re-
vealed interesting parallels to the vasculature. We have shown
that, during wound healing, intestinal smooth muscle gives riseto a population of myofibroblasts that migrate into the lamina
propria where they may be optimally positioned to signal to
regenerating epithelial cells. Indeed, the muscularis mucosa, a
classic histologic structure which has been historically assumed
to exclusively provide contractile functions during digestion such
as villusmovement andmicroperistalsis, is ideally located to pro-
vide a reservoir of myofibroblasts available for mobilization after
injury and may itself act as a source of paracrine signals. Once
activated, myofibroblasts, and possibly smooth muscle cells
within the muscularis mucosa, secrete an array of factors that
promote re-epithelialization includingWnt ligands, prostaglandin
E2 (PGE2), and cytokines such as IL-6 (Andoh et al., 2007; Powell
et al., 2011).
A role for miR-143/145 in the regulation of smooth muscle and
myofibroblast-derived paracrine signaling has not previously
been demonstrated in mammals. A related function, however,
has been proposed for miR-145 in the zebrafish gut where this
miRNA indirectly regulates intestinal smooth muscle secretion
of BMP4 and is therefore essential for normal epithelial morpho-
genesis during embryonic development (Zeng and Childs, 2012).
This function is clearly divergent from functions of miR-143/145
in mouse where, as shown here, deletion of these miRNAs is
compatible with normal intestinal development and does not
affect BMP4 expression (Figure S7B) nor BMP signaling at base-
line or after injury, as assessed by pSMAD1/5/8 staining of intes-
tinal epithelium (data not shown). Thus, in different vertebrate
species, miR-143/145 appears to regulate distinct aspects of
smooth muscle physiology.
We identified and validated one likely contributor to the intes-
tinal regenerative defect of miR-143/145-deficient mice in the
IGF binding protein IGFBP5. IGF signaling is recognized as a
potent stimulant for intestinal growth and repair in a variety of
settings, including glucocorticoid treatment, intestinal resection,
radiation injury, and DSS colitis (Howarth et al., 1998). IGF bind-
ing proteins (IGFBPs) typically function to competitively inhibit
IGF signaling and, accordingly, decreased phosphorylation
of epithelial IGF1R was observed in miR-143/145–/– mice. These
findings suggest amodel in which Igfbp5 derepression in smooth
muscle and myofibroblasts within zones of intestinal injury re-
sults in a net decrease in regeneration-promoting IGF signaling
(Figure 7). Nevertheless, future studies will be necessary to
determine the consequences of loss of function of Igfbp5 in
the context of miR-143/145 deletion to definitively establish the
necessity of the IGFBP5-IGF axis in this phenotype.
Given the diversity of pathways that participate in intestinal
epithelial regeneration, Igfbp5 derepression is likely only one
component of the perturbed signaling milieu generated by
miR-143/145 deletion. In addition, it is possible that the morpho-
logic abnormalities of miR-143/145–/– myofibroblasts directly
contribute to a signaling deficiency. Dynamic regulation of stro-
mal cell positioning in the lamina propria after DSS-mediated
injury has been shown to stimulate regeneration via more effi-
cient delivery of paracrine secreted factors to epithelial cells
(Brown et al., 2007). It is therefore plausible that the myofi-
broblast disorganization characteristic of knockout animals
reduces effective communication with regenerating cells. Taken
together, our observations support amultifaceted contribution of
structural and functional abnormalities of smooth muscle andCell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc. 1113
Figure 7. Model of miR-143/145 Action in Intestinal Epithelial Regeneration
Upon intestinal injury, lamina propria myofibroblasts derived from multiple sources, including smooth muscle, participate in the wound healing response. In the
absence of miR-143/145 (right side of figure), excessive secretion of IGFBP5 bymyofibroblasts results in sequestration of IGF ligand and diminished IGF pathway
activation within epithelial cells, likely contributing to the failure of epithelial cells to activate the regenerative proliferation program.myofibroblasts to regenerative failure in miR-143/145-deficient
mice. Elucidation of the full complement of targets of these
miRNAs that are responsible for these effects will provide further
insight into the control of mammalian epithelial repair by the
mesenchyme and uncover novel therapeutic strategies for hu-
man diseases related to epithelial proliferative dysfunction.EXPERIMENTAL PROCEDURES
Mouse Strains
miR-143/145Neo/+ mice were generated using homologous recombination
in ES cells in the Johns Hopkins Transgenic Core and subsequently crossed
to CMV-Cre and Actb-Flp mice (Jackson Laboratory) to generate miR+/– and
miRflox/+ mice, respectively. miR+/– and miRflox/+ mice were backcrossed
to C57BL6/J for over ten generations prior to performing the experiments
described here. All mouse experiments were approved by Institutional Animal
Care and Use Committees of the Johns Hopkins University School of Medicine
and The University of Texas Southwestern Medical Center.
DSS Treatment
Mice were treated with 3.5% w/v dextran sulfate sodium (DSS) of molecular
weight 36,000–50,000 (MP Biochemicals) in drinking water for 5 days. Solu-
tions of DSS were prepared in autoclaved tap water and passed through
0.45 mm cellulose acetate filters.
Histology, Immunofluorescence, and Immunohistochemistry
Intestinal segments were dissected, flushed with ice-cold saline, and
opened longitudinally. Samples were fixed for 24 hr in 10% neutral buff-
ered formalin and wrapped into ‘‘Swiss rolls’’ before standard tissue pro-
cessing and sectioning. Routine H&E staining was performed for general
histology. Immunostaining was performed as previously described (Shi
et al., 2009).1114 Cell 157, 1104–1116, May 22, 2014 ª2014 Elsevier Inc.Isolation of Intestinal Crypts
Mouse and human crypts were isolated as previously described (Sato et al.,
2009) with minor modifications (see Supplemental Information).
Isolation and Culture of ISEMFs
ISEMFs were isolated as previously described (Shaker et al., 2010) and main-
tained in high glucose DMEM media supplemented with 10% fetal bovine
serum (Invitrogen), 13 ITS supplement (Sigma), and 13 Antibiotic/Antimycotic
(Invitrogen). Treatment with 1 mg/ml LPS (Sigma) for 24 hr was used for micro-
array and qRT-PCR experiments.
In Situ Hybridization
In situ hybridization detection of miRNAs was performed using the miRCURY
LNA miRNA ISH Kit (Exiqon), with slight modifications to the manufacturer’s
protocol (see Supplemental Information). Igfbp5 ISH was performed as previ-
ously described (Acharya et al., 2012). The template for in vitro transcription
of the ISH probe directed against the Igfbp5 30UTR was generated by PCR
with primers specified in Table S2.
Statistical Analysis
Two-tailed Student’s t tests were performed to calculate p values, unless
specified otherwise. Error bars represent SDs.
See also Extended Experimental Procedures.
ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE55651.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
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